Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Stroke
Year: 2017, Volume: 48, Issue: 1, Pages: 145-151 |
| ISSN: | 1524-4628 |
| DOI: | 10.1161/STROKEAHA.116.014250 |
| Online Access: | Verlag, kostenfrei, Volltext: https://www.ncbi.nlm.nih.gov/pubmed/27932607 Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1161/STROKEAHA.116.014250 
|
| Author Notes: | Daniel Hänggi, Nima Etminan, Francois Aldrich, Hans Jakob Steiger, Stephan A. Mayer, Michael N. Diringer, Brian L. Hoh, J. Mocco, Herbert J. Faleck, R. Loch Macdonald |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581543239 | ||
| 003 | DE-627 | ||
| 005 | 20220815023706.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181004s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/STROKEAHA.116.014250 |2 doi | |
| 035 | |a (DE-627)1581543239 | ||
| 035 | |a (DE-576)511543239 | ||
| 035 | |a (DE-599)BSZ511543239 | ||
| 035 | |a (OCoLC)1341019436 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hänggi, Daniel |d 1970- |e VerfasserIn |0 (DE-588)1070887269 |0 (DE-627)824720172 |0 (DE-576)432795715 |4 aut | |
| 245 | 1 | 0 | |a Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]) |c Daniel Hänggi, Nima Etminan, Francois Aldrich, Hans Jakob Steiger, Stephan A. Mayer, Michael N. Diringer, Brian L. Hoh, J. Mocco, Herbert J. Faleck, R. Loch Macdonald |
| 264 | 1 | |c 2017 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Originally published December 8, 2016 | ||
| 500 | |a Gesehen am 04.10.2018 | ||
| 700 | 1 | |a Etminan, Nima |d 1978- |e VerfasserIn |0 (DE-588)134245202 |0 (DE-627)56561374X |0 (DE-576)300399871 |4 aut | |
| 700 | 1 | |a Steiger, Hans-Jakob |d 1953- |e VerfasserIn |0 (DE-588)1145654908 |0 (DE-627)1006846697 |0 (DE-576)166813672 |4 aut | |
| 700 | 1 | |a Mayer, Stephan A. |e VerfasserIn |0 (DE-588)1079559043 |0 (DE-627)842323783 |0 (DE-576)452793270 |4 aut | |
| 700 | 1 | |a Macdonald, Robert Loch |e VerfasserIn |0 (DE-588)129647748 |0 (DE-627)476245176 |0 (DE-576)184938244 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Stroke |d New York, NY : Association, 1970 |g 48(2017), 1, Seite 145-151 |h Online-Ressource |w (DE-627)266879985 |w (DE-600)1467823-8 |w (DE-576)075145731 |x 1524-4628 |7 nnas |a Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]) |
| 773 | 1 | 8 | |g volume:48 |g year:2017 |g number:1 |g pages:145-151 |g extent:7 |a Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]) |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pubmed/27932607 |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/STROKEAHA.116.014250 |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181004 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 134245202 |a Etminan, Nima |m 134245202:Etminan, Nima |d 60000 |d 62600 |e 60000PE134245202 |e 62600PE134245202 |k 0/60000/ |k 1/60000/62600/ |p 2 | ||
| 998 | |g 1070887269 |a Hänggi, Daniel |m 1070887269:Hänggi, Daniel |d 60000 |d 62600 |e 60000PH1070887269 |e 62600PH1070887269 |k 0/60000/ |k 1/60000/62600/ |p 1 |x j | ||
| 999 | |a KXP-PPN1581543239 |e 3027668250 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Originally published December 8, 2016","Gesehen am 04.10.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])","title_sort":"Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])"}],"relHost":[{"id":{"eki":["266879985"],"issn":["1524-4628"],"zdb":["1467823-8"]},"part":{"year":"2017","volume":"48","pages":"145-151","issue":"1","extent":"7","text":"48(2017), 1, Seite 145-151"},"corporate":[{"display":"American Heart Association","role":"isb"}],"pubHistory":["1.1970 -"],"disp":"Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])Stroke","physDesc":[{"extent":"Online-Ressource"}],"recId":"266879985","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 29.06.04"],"title":[{"title_sort":"Stroke","title":"Stroke","subtitle":"journal of the American Heart Association"}],"origin":[{"publisher":"Association ; Lippincott Williams & Wilkins","dateIssuedKey":"1970","publisherPlace":"New York, NY ; Philadelphia, Pa.","dateIssuedDisp":"1970-"}]}],"person":[{"family":"Hänggi","given":"Daniel","role":"aut","display":"Hänggi, Daniel"},{"display":"Etminan, Nima","family":"Etminan","role":"aut","given":"Nima"},{"display":"Steiger, Hans-Jakob","family":"Steiger","given":"Hans-Jakob","role":"aut"},{"family":"Mayer","role":"aut","given":"Stephan A.","display":"Mayer, Stephan A."},{"role":"aut","given":"Robert Loch","family":"Macdonald","display":"Macdonald, Robert Loch"}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017"}],"physDesc":[{"extent":"7 S."}],"recId":"1581543239","id":{"eki":["1581543239"],"doi":["10.1161/STROKEAHA.116.014250"]},"name":{"displayForm":["Daniel Hänggi, Nima Etminan, Francois Aldrich, Hans Jakob Steiger, Stephan A. Mayer, Michael N. Diringer, Brian L. Hoh, J. Mocco, Herbert J. Faleck, R. Loch Macdonald"]}} | ||
| SRT | |a HAENGGIDANRANDOMIZED2017 | ||